General Information of the Compound
| Compound ID |
CP0950279
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-4'-((4-(6-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yloxy)hexyl)piperazin-1-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methylbiphenyl-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Formula |
C53H65N7O8
|
||||||||||||||||||
| Molecular Weight |
928.144
|
||||||||||||||||||
| Canonical SMILES |
CCN(c1cc(-c2ccc(CN3CCN(CCCCCCOc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C53H65N7O8/c1-5-59(40-19-27-67-28-20-40)45-31-39(30-42(36(45)4)49(62)54-32-43-34(2)29-35(3)55-50(43)63)38-15-13-37(14-16-38)33-58-24-22-57(23-25-58)21-8-6-7-9-26-68-46-12-10-11-41-48(46)53(66)60(52(41)65)44-17-18-47(61)56-51(44)64/h10-16,29-31,40,44H,5-9,17-28,32-33H2,1-4H3,(H,54,62)(H,55,63)(H,56,61,64)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SYBFJJUKUKOTOQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound